logo
The 5 Most Interesting Analyst Questions From GE HealthCare's Q1 Earnings Call

The 5 Most Interesting Analyst Questions From GE HealthCare's Q1 Earnings Call

Yahoo25-06-2025
GE HealthCare's first quarter results came in above Wall Street expectations, as the company delivered broad-based revenue growth across all business segments. Management credited strong U.S. demand for imaging equipment—particularly in cardiology and oncology—as well as robust order activity and backlog expansion, for the positive momentum. CEO Peter Arduini highlighted, 'Record double-digit orders growth as a standalone company was driven by strength in the U.S. market, where we see customers prioritizing investments in imaging products.' The company also noted early market share gains and strong customer engagement as key contributors to the quarter's performance.
Is now the time to buy GEHC? Find out in our full research report (it's free).
Revenue: $4.78 billion vs analyst estimates of $4.66 billion (2.8% year-on-year growth, 2.5% beat)
Adjusted EPS: $1.01 vs analyst estimates of $0.91 (10.6% beat)
Adjusted EBITDA: $826.9 million vs analyst estimates of $794.4 million (17.3% margin, 4.1% beat)
Management lowered its full-year Adjusted EPS guidance to $4 at the midpoint, a 14.5% decrease
Operating Margin: 13.2%, up from 11.6% in the same quarter last year
Organic Revenue rose 4.1% year on year (-0.5% in the same quarter last year)
Market Capitalization: $32.96 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Larry Biegelsen (Wells Fargo) asked about the timing and magnitude of tariff impacts and the pace of mitigation. CFO Jay Saccaro explained that most mitigation will be realized in the second half of the year and further improvements are targeted for 2026.
Jason Bednar (Piper Sandler) inquired whether tariff mitigation actions were accelerated from long-range plans. CEO Peter Arduini clarified that while some actions were advanced, the broader margin and growth outlook remains unchanged.
Vijay Kumar (Evercore ISI) questioned the proportion of tariff headwinds tied to U.S.-China trade and the potential upside if tariffs are eased. Saccaro detailed that bilateral tariffs account for the majority of the impact and that a rollback could deliver substantial upside to earnings.
Robbie Marcus (JPMorgan) requested updates on Flyrcado's launch and potential anti-dumping risks in China. Arduini confirmed Flyrcado is on track and stated that recent anti-dumping investigations are not expected to materially impact the business.
Joanne Wuensch (Citi) probed the durability of hospital capital spending and the timeline for photon counting CT approval. Saccaro reported continued strength in U.S. and European demand, while Arduini reiterated that photon counting CT remains on schedule for regulatory submission.
In the coming quarters, the StockStory team will closely monitor (1) the pace and effectiveness of GE HealthCare's tariff mitigation strategies, (2) progress on new product rollouts, including Flyrcado and photon counting CT, and (3) sustainability of order growth and backlog conversion, particularly in key markets like China and the U.S. Updates on supply chain adjustments and the impact of shifting trade policy will also be important indicators of execution.
GE HealthCare currently trades at $71.99, up from $68.09 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it's free).
Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Erreur lors de la récupération des données
Connectez-vous pour accéder à votre portefeuille
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

California resident tests positive for plague after camping in South Lake Tahoe
California resident tests positive for plague after camping in South Lake Tahoe

USA Today

timea few seconds ago

  • USA Today

California resident tests positive for plague after camping in South Lake Tahoe

The infected person likely contracted the illness from a flea bite while camping, said health officials. A California resident has tested positive for plague after likely being bitten by an infected flea, health officials said on Tuesday, Aug. 19. The person was camping in the South Lake Tahoe area, located in the Sierra Nevada mountains in eastern California, the El Dorado County Public Health Division (EDCPHD) said in a statement. This is the first such infection reported in the county since 2020, when a case of human plague was also traced back to the South Lake Tahoe area, the public health division added. The resident is recovering at home under the supervision of a medical professional. What to know: Arizona resident dies of confirmed plague infection. Plague is caused by the bacterium Yersinia pestis and is most often transmitted to humans and other mammals via flea bites or handling infected animals. Rodent fleas spread the bacteria to people, dogs and cats after becoming infected by squirrels, chipmunks and other wild rodents. An average of seven people are diagnosed with a confirmed case of the plague each year in the United States, according to the U.S. Centers for Disease Control and Prevention, predominantly in the western part of the country. Typically, cases occur in northern New Mexico, northern Arizona, southern Colorado, California, southern Oregon, and far western Nevada. Over 80% of U.S. plague cases have been the bubonic form, also known as the "black plague," said the CDC. While the bubonic plague is famous for killing huge swathes of the European population during the Middle Ages, it is now treatable with antibiotics. 'Plague is naturally present in many parts of California, including higher elevation areas of El Dorado County," Kyle Fliflet, El Dorado County's acting director of public health, said in a statement. 'It's important that individuals take precautions for themselves and their pets when outdoors, especially while walking, hiking and or camping in areas where wild rodents are present." Health officials are investigating the situation, said EDCPHD. Symptoms of plague and how to protect yourself The three different types of plague — bubonic, septicemic and pneumonic — have some differing symptoms, though many of the fundamental signs are the same. According to the CDC and EDCPHD, symptoms of the most common form of plague in the United States, bubonic, appear within two weeks of exposure and include: To protect yourself from the small − yet real − chance of contracting plague, the agencies suggest:

Delta SkyMiles members and employees can vote to choose the airline's summer 2026 destination

time31 minutes ago

Delta SkyMiles members and employees can vote to choose the airline's summer 2026 destination

Delta Air Lines is letting its customers and employees decide where the airline will fly next summer. The airline announced its first-ever 'Route Race' contest Wednesday in which Delta's loyalty program and SkyMiles members, as well as Delta employees, get the opportunity to vote and choose a European destination the airline will add to its summer 2026 schedule. Beginning August 25th through August 29th, SkyMiles members and Delta employees can vote using the Fly Delta App for one of the three European destinations – Sardinia, Malta, and Ibiza – for next summer. Delta will announce the winning destination within 30 days after voting closes. 'SkyMiles Members and Delta people are at the center of everything Delta does. The Route Race is a celebration of their influence, giving our community a voice in where they want to fly next and inviting them to help shape Delta's global network,' said Paul Baldoni, Delta's senior vice president of network planning. 'The destinations where Delta flies are more than just dots on a map – they're gateways to culture, connection and possibility, and this is a chance for our Members and employees to bring one of them closer." Describing the three destinations, Delta said Sardinia, Italy, is a slower-paced but adventurous option with natural beauty, history and food. Malta was described as the escape that blends centuries of history with sunny Mediterranean charm. Ibiza was pitched as the global capital of nightlife with its world-famous DJs, beach parties and laid-back beach bars. Delta currently flies to more than 300 destinations. This summer, the airline said it operated its largest-ever transatlantic schedule.

Iran FM, IRGC chief warn that hostilities could resume
Iran FM, IRGC chief warn that hostilities could resume

Yahoo

timean hour ago

  • Yahoo

Iran FM, IRGC chief warn that hostilities could resume

Araghchi hinted that financial compensation may be necessary for Tehran to reenter negotiations with the US, mirroring sentiments previously expressed to the Financial Times. In separate statements, Iranian Foreign Minister Abbas Araghchi and the commander-in-chief of Iran's military, Amir Hatami, said that Iran could still strike Israel. Hatami told state media that threats from Israel still persist. "A 1% threat must be perceived as a 100% threat. We should not underestimate the enemy and consider its threats as over," Hatami said, according to the official IRNA news agency, adding that the Islamic Republic's missile and drone power "remains standing and ready for operations." Araghchi claimed earlier that there was no established ceasefire between Tehran and Jerusalem in an interview with the Iranian Student News Agency. 'The aggression has stopped, and in turn our right to defend has stopped,' Araghchi said. ' That's it. There is no ceasefire agreement; there is nothing else. They stopped the aggression without any conditions, and we stopped the defense. When there is no aggression, naturally, there is no reason to defend ourselves. So since they asked for the attacks to stop without any conditions, we accepted. 'Everything can resume. They can resume, we can resume. There is no official ceasefire, and everything is possible, and it is not just Iran that should be worried and concerned.' In the same interview, the regime official asserted that it was necessary for the regime to continue enriching uranium and that Iranian healthcare was dependent on an enrichment of at least 20%. Iran's nuclear talks While Iran has held discussions with a number of European officials since talks with the US failed, Araghchi said, 'Why should we continue negotiations with them? So there is only one reason to negotiate with the Europeans, and that is the trigger mechanism. Because they cannot lift or terminate the sanctions, they cannot stop the aggression. They cannot do anything. The only leverage they think they have is the possibility of activating the trigger mechanism, and if they do that, everything is over and they will no longer play any role in the future of the Iranian nuclear negotiations.' He alleged that there was strong pressure in Tehran to walk away from any negotiations, claiming that the recent 12-day war signalled the Trump administration was disinterested in reaching any real agreement. Araghchi hinted that financial compensation may be necessary for Tehran to reenter negotiations with the US, mirroring sentiments previously expressed to the Financial Times. 'Financial compensation for what has been imposed on us, and of course, as you know, a significant number of our people have been martyred in these attacks. So we cannot simply return to negotiations and pretend that everything is normal. The situation is no longer the same,' he said. 'They have attacked us. Our facilities have been severely damaged. So we cannot enter negotiations and pretend that nothing has happened. This is obvious. So this time the negotiations will be much more difficult, and they must understand that by attacking our nuclear facilities, they have not made the path of negotiations easier, but rather more complicated and difficult.' While acknowledging that Operation Rising Lion had damaged much of Tehran's nuclear capabilities, Araghchi claimed that Iran was capable of restoring the facilities. 'Although many advanced centrifuges have been lost in Fordow and Natanz, we can still enrich, we still have the capacity to enrich uranium after the attacks,' he said. '...We have the theoretical and practical knowledge of it…We had everything before the attacks. The buildings are rebuilt and the machines are replaced because the technology is there; we have many scientists and technicians who were working in our facilities, and, as I said, we have the ability to do this. But when and how we resume enrichment depends on the circumstances.' Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store